Oppenheimer & Co’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Oppenheimer & Co’s Portfolio IBDQ Stock Details IBDQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,236	Closed	-$332K	–	1598
2024 Q3	$332K	Buy	+13,236	New	+$330K	0.01%	1184
2023 Q4	–	Sell	-21,529	Closed	-$525K	–	1415
2023 Q3	$525K	Buy	21,529 +1,160	+6%	+$28.3K	0.01%	930
2023 Q2	$497K	Buy	20,369 +298	+1%	+$7.3K	0.01%	975
2023 Q1	$492K	Sell	20,071 -153	-0.8%	-$3.74K	0.01%	946
2022 Q4	$492K	Buy	+20,224	New	+$490K	0.01%	914

Other funds holding IBDQ

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

SVWAG

Sound View Wealth Advisors Group Savannah, Georgia $1.47B AUM 18.47% 1-Year Est. Return

Oppenheimer & Co's IBDQ Position: Q4 2024 in Review

Oppenheimer & Co sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2024, closing a stake of 13,236 shares — an estimated $332K sold.

Oppenheimer & Co first reported a position in IBDQ in Q4 2022 and held it in 5 quarters. The position peaked at $525K in Q3 2023. 389 funds tracked by Wall St. Rank hold IBDQ as of Q4 2024.

Oppenheimer & Co reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2024 after selling out during the quarter.
Oppenheimer & Co sold 13,236 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2024, an estimated $332K.
Oppenheimer & Co first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2022 and held it in 5 quarters.
Oppenheimer & Co's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $525K in Q3 2023.
389 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2024.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.